News Releases

Children and adolescents who received one of the main COVID-19 vaccines were significantly protected from the illness and showed no increased signs of cardiac complications compared to young people who were not vaccinated.

Researchers have identified potential clues that may enhance current vaccines through a detailed analysis of immune responses to breakthrough infections.

Patients with long COVID can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.

A new test by PSOM researchers will allow multiple sclerosis patients to know how their bodies’ immune systems responded to the COVID-19 vaccine.

The historic scientific breakthrough at the Perelman School of Medicine at the University of Pennsylvania that helped lead the world’s fight against COVID-19 through mRNA-based vaccines is being commemorated through a non-fungible token—a digital asset to be auctioned by Christie’s—that will support ongoing research at Penn.

A collection of human DNA variants tied to more severe cases of COVID-19 are also associated with other serious medical conditions such as those dealing with blood clots and faulty inflammatory responses, according to a new study.